Helius
Software · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.heliuscorp.comRevenue
<$5 MillionIndustry
About Helius
Helius Org Chart
Is Helius your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Helius, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Helius is spiking on competitors!
Earning: See what the market has to say on Helius recently announced quarterly report
Click to see if Helius had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Helius has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Helius has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Helius
Product Launch: Get notified when Helius launches new products
Recommended Actions
Find VP level buyers at Helius
Find 2 more new buyers
Company Profile Activity
Activity Insights
Helius is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Helius is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Helius.
Helius Tech Stack
A closer look at the technologies used by Helius
Helius News & Media
Helius Medical Technologies, Inc. Comments on Unusual Market Activity
NEWTOWN, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, is issuing this news release in light of unusual trading activity related to the shares of Class A Common Stock of Helius (the "Shares") on the Toronto Stock Exchange and The Nasdaq Capital Market. In view of such activity, The Nasdaq Capital Market and the Investment Industry Regulatory Organization ofHelius Medical Technologies, Inc. Announces Reverse Stock Split
NEWTOWN, Pa., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announced today a 1-for-35 reverse split of its Class A common stock, par value $0.001 (“common stock”), effective at 5:00 pm Eastern time today. Beginning on January 4, 2021, the Company’s common stock will trade on The Nasdaq Capital Market and the Toronto Stock Exchange on a split adjusted basis.Helius Medical Technologies, Inc. Reports Third Quarter of Fiscal Year 2020 Financial Results
NEWTOWN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended September 30, 2020.Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November
NEWTOWN, Pa., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that management will participate in the following upcoming investor conferences:
Top Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Helius
In today's competitive environment, business leaders cannot afford to be bogged down with a slow-moving loan approval process. At HELUIS , we are committed to providing business leaders with the personal attention and quick turnaround time needed to succeed. From the very beginning, our business model was designed to uniquely serve businesses and t... Read More